GVGabriela María Rivera Vega

Gabriela María Rivera Vega

*This is an algorithmically generated author record based on publicly available information.

Gabriela María Rivera Vega has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Índice de choque ajustado a la edad pediátrica como herramienta para predecir mortalidad en pacientes con dengue

    by Gabriela María Rivera Vega, Arlen Melisa Caballero, Wilmer Alejandro Madrid Mejía

    Introduction: The pediatric age-adjusted shock index (SIPA), defined as the ratio between heart rate (HR) and systolic blood pressure (SBP), is widely used as a predictor in patients with trauma or acute hemorrhage and in hypovolemic shock. Since dengue can lead to a state of shock, this index may be useful as a prognostic marker of severity. Objective: To identify the relationship between SIPA and the risk of morbidity and mortality in patients aged 1 to 17 years with dengue presenting with warning signs or severe dengue. Methods: Observational, descriptive, prospective, cross-sectional study. A total of 145 pediatric patients diagnosed with dengue with warning signs or severe dengue were included, treated between February 1, 2024, and August 31, 2024, at Mario Catarino Rivas Hospital. The shock index was assessed upon admission and 24 hours later. Results: Patients aged 1 to 6 years presented the highest SIPA values at admission, with a median close to 1.1, which decreased significantly after 24 hours. In deceased patients, SIPA was significantly higher both at admission and 24 hours later, with a fatal outcome. In patients older than 12 years, SIPA values were lower at admission and at 24 hours. Sex-based analysis showed that females had a significantly higher SIPA at admission (p = 0.0166). No statistically significant association was found between SIPA and admission to the PICU (p = 0.36). Conclusion: As a mortality predictor, SIPA was significantly higher in patients who died. Improvement in SIPA was associated with favorable clinical evolution.

  • Reporte de Caso: Miopatía Nemalínica en una lactante con hipotonía

    by Gabriela María Rivera Vega, María Alejandra Galindo Cueva, Linda Yajeira Banegas Pineda, Mario Velásquez

    Introduction: Nemaline myopathies (NM) are a group of congenital myopathies characterized by early-onset muscle weakness and hypotonia. They result from mutations in genes encoding structural or regulatory proteins of the thin filament, with NEB and ACTA1 being the most frequently affected. The availability of next-generation sequencing has facilitated the identification of causal variants, enabling genotype-phenotype correlations and guiding clinical management. Case Report: We present a three-month-old female infant, with no relevant prenatal history, who since birth exhibited weak crying, poor sucking and swallowing, with episodes of regurgitation and bronchoaspiration. Physical examination revealed generalized hypotonia, reduced spontaneous movements, absent deep tendon reflexes, and mild craniofacial dysmorphism. Brain CT showed corpus callosum hypoplasia, while metabolic studies and muscle enzyme levels were normal. Genetic testing identified two pathogenic variants in the NEB gene (c.1493A>G and c.17828del), confirming the diagnosis of autosomal recessive nemaline myopathy. The patient required supportive interventions, including Nissen fundoplication, gastrostomy, and tracheostomy due to respiratory failure, along with physical and respiratory therapy and pharmacological management with L-tyrosine. She is currently being prepared for home mechanical ventilation. Conclusions: Hypotonia in infants represents a diagnostic and therapeutic challenge, particularly in resource-limited settings. Access to genetic testing is crucial to confirm etiology, guide multidisciplinary management, and provide families with a more accurate prognosis. The identification of specific gene mutations associated with NM opens the door to potential targeted therapies, aiming to improve quality of life and survival in affected patients.

  • Open Access

    Complejo Limb-Body Wall fenotipo placento-abdominal: reporte de caso

    by Nelson Rodríguez Paz, Gabriela María Rivera Vega, Reenie Helena Pineda Villeda

    Antecedentes: El complejo Limb-Body Wall (LBWC) es una anomalía congénita rara con variaciones en el espectro de presentación clínica de malformaciones en la pared corporal asociado a deformidad de extremidades y viscerales. Se presenta en 0.4 y 3.2 por cada 100,000 nacidos vivos a nivel mundial. El diagnóstico se obtiene con la presencia de una combinación de dos de tres criterios: toraco o abdominoquisis, exencefalia/ encefalocele con hendiduras faciales y defectos en miembros. Descripción de caso clínico: Se presenta recién nacido de 34 semanas de gestación por valoración de test Capurro. Al examen físico, con peso 2,480 gramos, 43 cm de talla, normocéfalo con perímetro cefálico 32.5 cm, perímetro torácico 25 cm, a la auscultación cardiopulmonar, pulmones hipoventilados, ruidos cardiacos audibles de bajo tono, bradicárdico con onfalocele conteniendo asas de intestino delgado y segmento de hígado con adherencia a placenta en su cara materna en 20% de su superficie sin presencia de cordón umbilical. Se observa escoliosis y pelvis de hemicuerpo izquierdo con estructura ósea prominente y ano imperforado. En extremidad inferior izquierda se observó hipoplásica con pie equinovaro. El recién nacido falleció a los 20 minutos de vida por falla cardíaca, insuficiencia respiratoria y a causa de múltiples malformaciones. No se realizaron estudios genéticos, por la falta de recursos económicos. Conclusión: El LBWC es un defecto congénito extremadamente raro de la pared abdominal ventral con mal pronóstico intraútero y al nacimiento. Presentamos el primer caso reportado en la literatura científica de Honduras del complejo Limb-Body Wall nacido en Hospital Nacional Mario Catarino Rivas, San Pedro Sula, Honduras.


  • Open Access

    Tuberculosis Cutánea

    by Gabriela María Rivera Vega, Nataly Yamaly Martínez Yanes